Telomere dysfunction and evolution of intestinal carcinoma in mice and humans
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Telomerase activation is a common feature of advanced human cancers and facilitates the malignant transformation of cultured human cells and in mice. These experimental observations are in accord with the presence of robust telomerase activity in more advanced stages of human colorectal carcinogenesis. However, the occurrence of colon carcinomas in telomerase RNA (Terc)-null, p53-mutant mice has revealed complex interactions between telomere dynamics, checkpoint responses and carcinogenesis. We therefore sought to determine whether telomere dysfunction exerts differential effects on cancer initiation versus progression of mouse and human intestinal neoplasia. In successive generations of ApcMin Terc-/- mice, progressive telomere dysfunction led to an increase in initiated lesions (microscopic adenomas), yet a significant decline in the multiplicity and size of macroscopic adenomas. That telomere dysfunction also contributes to human colorectal carcinogenesis is supported by the appearance of anaphase bridges (a correlate of telomere dysfunction) at the adenoma-early carcinoma transition, a transition recognized for marked chromosomal instability. Together, these data are consistent with a model in which telomere dysfunction promotes the chromosomal instability that drives early carcinogenesis, while telomerase activation restores genomic stability to a level permissive for tumor progression. We propose that early and transient telomere dysfunction is a major mechanism underly…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We monitored the anaphase bridge index (ABI), an in vivo biomarker of the degree of telomere dysfunction in dividing tissues that mirrors chromosomal fusion frequency, in successive mTerc -/ -generations (7, 30) (see Materials and Methods for definition of ABI).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [30]
In the citing paper
“The GI crypts of lategeneration mTerc -/ -Ink4a / Arf + / + and -/ -mice exhibited equally high levels of apoptosis (Fig. 1 C ), comparable to that in late-generation mTerc -/ -tissues with intact p53 function (7, 30).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [30]
In the citing paper
“This finding differs from that of the mTerc Apc Min model, wherein telomere dysfunction promotes the initiation of intestinal carcinomas but inhibits their progression (30).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [30]
In the citing paper
“findings consistent with previous studies establishing that telomere dysfunction acts as a tumor suppressor when p53 function is intact (7, 8, 30, 48).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [30]
In the citing paper
“Crosses of telomerase-deficient mice with various tumour model mice have demonstrated that critically short telomeres limit tumour formation when the p53 pathway is functional51–55.”
From Telomeres in cancer: tumour suppression and genome instability (2017) · cites this paper as [52]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 1×
“gif" NDATA ITEM> ]> Telomerase activation is a common feature of advanced human cancer”
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168 · cited 1×
“Epithelial cancers occur infrequently in laboratory mice, and when they do occur they rarely exhibit the aberrant cytogenetic profiles typical of human carcinomas, such as severe aneuploidy and complex nonreciprocal translocation”
BackgroundCreation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345 · cited 1×
“and facilitates the malignant transformation of cultured human cell”
BackgroundTelomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Self-citationTRF2 Protects Human Telomeres from End-to-End Fusions
van Steensel, B., Smogorzewska, A., & de Lange, T. (1998) · Cell · doi:10.1016/s0092-8674(00)80932-0 · Cited by 1,709
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650 · cited 1×
“Together, the presence of short telomeres in colorectal carcinom”
BackgroundTHE STABILITY OF BROKEN ENDS OF CHROMOSOMES IN ZEA MAYS
McClintock, B. (1941) · Genetics · doi:10.1093/genetics/26.2.234 · Cited by 1,596
A Dominant Mutation That Predisposes to Multiple Intestinal Neoplasia in the Mouse
Moser, A. R., Pitot, H. C., & Dove, W. F. (1990) · Science · doi:10.1126/science.2296722 · Cited by 1,591 · cited 1×
“In successive generations of Apc Min Terc −/− mic”
BackgroundMultiple Intestinal Neoplasia Caused by a Mutation in the Murine Homolog of the APC Gene
Su, L.-K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A., & Dove, W. F. (1992) · Science · doi:10.1126/science.1350108 · Cited by 1,536
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349
Self-citation
Cited by
Items 401–500 of 521
Breakage of CRISPR/Cas9-Induced Chromosome Bridges in Mitotic Cells
Rodriguez‐Muñoz, M., Garcia, M. S., Soler, D., Genescà, A., & Anglada, T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.745195 · Cited by 6
Habib, A. G. K., Sugiura, K., & Ueno, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190523 · Cited by 6
Associations of TERT polymorphisms with hepatocellular carcinoma risk in a Han Chinese population.
Zhang, Y., Wang, S., Shi, Y., Cao, Y.-F., He, H., Zhou, S., Luo, S., Wen, X., Chen, Y., Liu, H., et al. (2017) · PubMed · Cited by 7
Brodie, C. M., Crotty, P., & Gaffney, E. F. (2004) · Histopathology · doi:10.1111/j.0309-0167.2004.01813.x · Cited by 6
Colorectal Cancer Therapeutics and the Challenges of Applied Pharmacogenomics
Kruzelock, R. P., & Short, W. (2007) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2007.05.001 · Cited by 6
CHK2‐independent induction of telomere dysfunction checkpoints in stem and progenitor cells
Nalapareddy, K., Choudhury, A. R., Gompf, A., Ju, Z., Ravipati, S., Leucht, T., Lechel, A., & Rudolph, K. L. (2010) · EMBO Reports · doi:10.1038/embor.2010.83 · Cited by 8
Self-citationKatavic, S., Cehic, I., Zukic, N., Mirvic, M., Dizdar, M., Gutalj, A., Medić, B. Š., Jerković-Mujkić, A., Mahmutović-Dizdarević, I., & Mešić, A. (2023) · Drug and Chemical Toxicology · doi:10.1080/01480545.2023.2222928 · Cited by 5
“…so they are only fleetingly exposed to the consequences of active dicentric chromosomes (Gascoigne and cheeseman, 2013). telomere fusion events are found in tumors, such as giant cell tumor of the bone and meningioma (MacKinnon and campbell 2011), as well as intestinal carcinoma (Rudolph et al .”
BackgroundDistribution of Telomere Length in the Cord Blood of Chinese Newborns
Lim, S.-N. (2013) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2013/2676 · Cited by 6
“Mice with shorter telomeres have increased incidence of tumour formation [9,10].”
BackgroundTargeting Telomerase in Hematologic Malignancy
Maritz, M. F., Napier, C. E., Wen, V. W., & MacKenzie, K. L. (2010) · Future Oncology · doi:10.2217/fon.10.42 · Cited by 5
“Chromatids that are joined by telomere fusions break unevenly during mitosis and give rise to abnormal chromosome structures and drive genetic instability [20–22].”
BackgroundLadeira, C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-411471-5.00020-x · Cited by 5
Aref, S., Saeed, A. A., Menshawy, N. E., Abdalla, D., & Ashery, M. E. (2019) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23133 · Cited by 6
Shortened Telomeres: A Driving Force Behind Leukemia?
Pepper, C. J., & Baird, D. M. (2010) · Future Oncology · doi:10.2217/fon.10.135 · Cited by 6
“This model is consistent with evidence from telomerase knockout mice, where mice with short telomeres are tumor prone, and demonstrate a change in the spectrum of tumor types from mesenchymal tumors to carcinoma facilitated by the loss of p53 [15,16].”
BackgroundResultBapat, B. V., & Perera, S. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/38427 · Cited by 6
“At the same time it was seen that telomere loss can inhibit tumour progression and the development of macroscopically advanced tumours[ 94-97 ].”
BackgroundCentromere Protein F in Tumor Biology: Cancer's Achilles Heel
Wan, Z., Wen, M., Zheng, C., Sun, Y., Zhou, Y., Tian, Y., Xin, S., Wang, X., Ji, X., Yang, J., et al. (2025) · Cancer Medicine · doi:10.1002/cam4.70949 · Cited by 5
The Role of Telomeres in Liver Disease
Sunami, Y., von Figura, G., Kleger, A., Strnad, P., Hüser, N., & Hartmann, D. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397898-1.00007-4 · Cited by 5
Albosale, A. H., & Mashkina, E. V. (2021) · Balkan Journal of Medical Genetics · doi:10.2478/bjmg-2021-0026 · Cited by 4
“Shortened telomere length is associated with complex, nonreciprocal chromosomal translocations, genome amplification, deletion via breakage–fusion–bridge (BFB) cycles, and the development of epithelial carcinomas and other malignancies [31,32].”
BackgroundShingu, T., Jaskelioff, M., Yuan, L., Ding, Z., Protopopov, A. I., Kost‐Alimova, M., & HU, J. L. (2015) · Journal of Visualized Experiments · doi:10.3791/52599 · Cited by 5
Krebs und Alter – biologische Grundlagen
von Figura, G., & Rudolph, K. L. (2009) · Onkologie · doi:10.1159/000228653 · Cited by 6
Self-citationLynch, J. P., & Rustgi, A. K. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00080-4 · Cited by 4
Multiple telomeric aberrations in a telomerase-positive leukemia patient
Serakıncı, N., Østergaard, M., Larsen, H., Madsen, B., Pedersen, B., & Koch, J. (2002) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(02)00533-2 · Cited by 4
Torres-Montaner, A. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.01.003 · Cited by 5
MacKinnon, R. N., Duivenvoorden, H. M., Campbell, L. J., & Wall, M. (2016) · Cytogenetic and Genome Research · doi:10.1159/000456677 · Cited by 4
“The evidence that telomere erosion/telomere fusion causes genome instability in cancer is generally indirect, such as shortened telomeres or the presence of anaphase bridges [Rudolph et al., 2001; Gordon et al., 2003; Letsolo et al., 2010; Jones et al., 2012].”
BackgroundTelomere Structural Dynamics in Genome Integrity Control and Carcinogenesis
Greenberg, R. A., & Rudolph, K. L. (2006) · Springer eBooks · doi:10.1007/1-4020-3764-3_11 · Cited by 3
Self-citationTekisogullari, K., & Topçul, M. (2013) · PubMed · Cited by 3
Genetic Instability in Cancer: An Optimal Control Problem
Wan, F. Y. M., Sadovsky, A. V., & Komarova, N. L. (2010) · Studies in Applied Mathematics · doi:10.1111/j.1467-9590.2009.00476.x · Cited by 6
“There is growing biological evidence that the degree of genetic instability is high at relatively early stages of carcinogenesis, and decreases as cancer progresses [15, 16].”
BackgroundResultTelomere stability and carcinogenesis: an off-again, on-again relationship
Wanat, J. J., & Johnson, F. B. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63979 · Cited by 5
Selective protection of zidovudine‐induced DNA‐damage by the antioxidants WR‐1065 and tempol
Olivero, O. A., Ongele, M. O., Braun, H. M., Marrogi, A., Divi, K., Mitchell, J. B., & Poirier, M. C. (2014) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21872 · Cited by 3
“It has been proposed that NPBs may be surrogate markers for telomeric shortening [Rudolph et al., 2001].”
BackgroundMurine Models of Dysfunctional Telomeres and Telomerase
Liu, Y., & Harrington, L. A. (2012) · Wiley eBooks · doi:10.1002/9781118268667.ch9 · Cited by 3
Chicurel, M. (2001) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2001.1.oa3 · Cited by 3
Chromosome segregational defects: their origin, fate and contribution to genomic instability
Luo, L. (2005) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 3
Telomere length dynamics in aging mice
Comartin, P. J. (2012) · Scholarship@Western (Western University) · Cited by 2
Ilié, M., Lantéri, E., Chamorey, E., Thamphya, B., Hamila, M., Montaudié, H., Picard‐Gauci, A., Gardrat, S., Passeron, T., Lassalle, S., et al. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1901446 · Cited by 2
“The TRF2 protein is a key factor in telomere protection, which contributes to oncogenesis.(37,38) While elevated TRF2 expression is observed in a large number of solid malignancies, notably carcinomas, little is known about its oncogenic and clinical role in melanoma.”
BackgroundTelomerase exerts physiological and tumor promoting functions by stimulating ribosomal biogenesis
Iben, S., & Güneş, Ç. (2015) · Telomere and Telomerase · doi:10.14800/tt.433 · Cited by 2
“In experimental models, depletion of telomerase results in telomere shortening, limiting self renewal capacity of stem cells, exhaustion of the stem cell pool and finally promoting premature aging whereas dysfunctional telomeres can cause age-related pathologies, depending on the functionality of the DNA-repair machin…”
BackgroundTelomere dysfunction suppresses multiple endocrine neoplasia in mice
Lee, J., Anver, M. R., Kost‐Alimova, M., Protopopov, A. I., DePinho, R. A., & Rane, S. G. (2014) · Genes & Cancer · doi:10.18632/genesandcancer.31 · Cited by 2
“Telomerase deficiency in combination with mutations in distinct tumor suppressor genes, except p53, significantly diminishes tumorigenesis potential [36-40] suggesting that telomerase inhibitors may be effective as anti-cancer agents [41-43].”
BackgroundSelf-citationTelomeres and Telomerase: Distinctive Roles in Liver Regeneration, Cirrhosis and Carcinogenesis
Ande, S., & Rudolph, K. L. (2005) · Springer eBooks · doi:10.1007/3-540-27194-5_28 · Cited by 2
“In line with the DNA-damage hypothesis of telomere dysfunction, impaired tumor progression was associated with an upregulation of p53 protein in tumors of mTERC – /– mice, resulting in elevated rates of tumor cell apoptosis and reduced rates of tumor cell proliferation [ 58 ].”
BackgroundSelf-citationMurata, M. M., Giuliano, A. E., & Tanaka, H. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3163-8_2 · Cited by 3
Gutierrez, L. G., & Ju, Z. (2007) · Springer eBooks · doi:10.1007/978-3-540-73709-4_8 · Cited by 6
Telomerase Mutations and Premature Ageing in Humans
Du, H., Bessler, M., & Mason, P. J. (2007) · Springer eBooks · doi:10.1007/978-3-540-73709-4_5 · Cited by 2
Telomere Binding Proteins and Disease
Blasco, M. A. (2007) · Springer eBooks · doi:10.1007/978-3-540-73709-4_12 · Cited by 2
Modeling Human Colorectal Cancer in Mice for Chemoprevention Studies
Lipkin, M., & Lamprecht, S. A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59259-768-0_4 · Cited by 2
A Practical Approach for Targeting Structural Variants Genome-wide in Plasma Cell-free DNAPreprint
Murata, M. M., Igari, F., Urbanowicz, R. J., Mouakkad, L., Kim, S., Chen, Z., Vizio, D. D., Posadas, E. M., Giuliano, A. E., & Tanaka, H. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.25.564058 · Cited by 2
“37 Therefore, DNA palindromes can arise very early during carcinogenesis and may serve as valuable cancer biomarkers in both early and late-stage tumors.”
Using mice to unveil the genetics of cancer resistance
van der Weyden, L., & Adams, D. J. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.05.003 · Cited by 3
Wang, Q., Sun, X., Han, X., Zhang, X., Wang, W., Wang, H., Ren, H., & Gu, L. (2026) · MedComm – Oncology · doi:10.1002/mog2.70054 · Cited by 2
Multiomics Research Strategies in Cancer: A Growing and Innovative Field
Du, Z., Liu, X., Lv, Z., Wang, B., Xia, Y., Al-duais, W. A. M., Yan, L., Zhang, F., & Li, Y. (2026) · MedComm · doi:10.1002/mco2.70644 · Cited by 2
Slijepčević, P. (2007) · Acta Medica Academica · Cited by 1
Molecular Signaling Pathways in Pancreatic Cancer
Boland, G. M., & Thayer, S. P. (2008) · Springer eBooks · doi:10.1007/978-0-387-69252-4_11 · Cited by 3
Strategies to Eliminate Cancer Stem Cells
Jones, R. J. (2007) · Springer eBooks · doi:10.1007/2789_2007_052 · Cited by 1
“In fact, crossing telomerase-knockout mice with INK4a –/– (Greenberg et al. 1999) or APC min ( Rudolph et al. 2001 ) mice predisposed to cancer signifi-”
BackgroundTelomere Shortening and Telomerase Activation during Cancer Formation
Rudolph, K. L. (2007) · Springer eBooks · doi:10.1007/978-3-540-73709-4_11 · Cited by 1
“In agreement with the pivotal role of p53 in human carcinogenesis, tumor suppression in telomere-dysfunctional mice is associated with an activation of p53 in tumor cells as well as with increased rates of tumor cell apoptosis and impaired tumor cell proliferation (Rudolph et al. 2001).”
BackgroundSelf-citationMouse Model: Telomeres and Telomerase in Stem Cell and Cancer
Huang, X., & Ju, Z. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-879-9_6 · Cited by 1
“The dual role of telomere shortening interconnects with telomerase activation, which is required for further tumor progression next to the initiation of microscopic tumor ( 35 ).”
BackgroundInfluentialTelomeres and Telomerase: Molecular Views and Perspectives
Arvind, K., & Grace, T. (2018) · Advances in Aging Research · doi:10.4236/aar.2018.75008 · Cited by 2
“Studies suggest that hTERT is frequently expressed during the early tumor development and allows the clone to bypass mitotic breakdown and replicative senescence and thus causes the malignant to get immortalized [87] [88].”
BackgroundThe role of BRCA2 in the fragility of interstitial telomeric sites
Chianea, Y. G., Roberts, T., & Slijepčević, P. (2022) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2022.503476 · Cited by 1
Regulation of the Liver Cell Mass
Malek, N. P., Rudolph, K. L., & Diehl, A. M. (2007) · Wiley eBooks · doi:10.1002/9780470691861.ch2e · Cited by 1
Self-citationMolecular Genetics and Cytogenetics in Cancer
Sayagués, J. M., Roa, S., Gutierrez, N. C., & Renault, I. Z. (2011) · Genetics Research International · doi:10.4061/2011/835053 · Cited by 2
Cancer, Senescence, and Aging: Translation from Basic Research to Clinics
LLeonart, M. E., Carnero, A., Paciucci, R., Wang, Z., & Shomron, N. (2011) · Journal of Aging Research · doi:10.4061/2011/692301 · Cited by 3
Kodama, S. (2005) · International Congress Series · doi:10.1016/j.ics.2004.11.134 · Cited by 1
Telomere biology: Implications for radiation carcinogenesis
Kodama, S., Ariyoshi, K., Watanabe, S., Shiraishi, K., & Watanabe, M. (2007) · International Congress Series · doi:10.1016/j.ics.2006.10.010 · Cited by 1
Papillomavirus infection and telomerase activation
Allen, H. K., & Klingelhutz, A. J. (2003) · Papillomavirus Report · doi:10.1179/095741903225001598 · Cited by 1
Sharrow, A. C., Ghiaur, G., & Jones, R. J. (2015) · Wiley eBooks · doi:10.1002/9781118468678.ch4 · Cited by 1
Hahn, W. C. (2003) · Cancer Research and Treatment · doi:10.4143/crt.2003.35.6.467 · Cited by 1
Telomeres and Telomerase in Liver Generation and Cirrhosis
Schaetzlein, S., & Rudolph, K. L. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch74 · Cited by 1
Self-citationWeiß, A. G. (2024) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10273 · Cited by 1
A Practical Approach for Targeting Structural Variants Genome-wide in Plasma Cell-free DNAPreprint
Tanaka, H., Murata, M. M., Igari, F., Urbanowicz, R. J., Mouakkad, L., Kim, S., Chen, Z., Vizio, D. D., Posadas, E. M., & Giuliano, A. E. (2024) · Research Square · doi:10.21203/rs.3.rs-3492157/v1 · Cited by 1
“32,33 Importantly, anaphase bridges between dividing nuclei, an indication of segregating dicentric chromosomes, were observed in preneoplastic regions, 34 suggesting that DNA palindromes can arise very early during carcinogenesis, and thus can potentially be an excellent cancer biomarker.”
BackgroundImplication du système télomères/télomerase au cours de la mastocytose
Georgin‐Lavialle, S. (2011) · theses.fr (ABES) · doi:10.70675/7de7d9a4z35a6z4313z8cf3z261ec926493e · Cited by 2
Genomic DNA Copy Number Alterations in Mouse Cancer Models and Human Cancer
Albertson, D. G. (2011) · Springer eBooks · doi:10.1007/978-0-387-69805-2_8
Replicative Senescence as an Intrinsic Tumor-Suppressor Mechanism
Chang, S. S. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1075-2_8
Maintenance of Telomeres in Cancer
Denchi, E. L. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1770-6_8
“For example, during the transition from adenoma to carcinomas frequent anaphase bridges, an indicator of end-to-end chromosome fusions, are observed in colorectal carcinomas ( Rudolph et al., 2001 ) and oral squamous cell carcinomas (Gordon et al., 2003).”
BackgroundNovel radiation targets in the endothelium and heart muscle
Yentrapalli, V. R. (2013) · DiVA (Stockholm University)
Antagonistic Pleiotropy: The Role of Smurf2 in Cancer and Aging: A Dissertation
Ramkumar, C. (2012) · eScholarship@UMassChan · doi:10.13028/b1er-s046
“Mice deficient in the telomerase RNA component (mTERC−/−) gradually lose telomeres over several generations [88] and tumorigenesis is significantly reduced in late generations of mTERC−/− mice with telomere attrition [89-93].”
BackgroundCellular aging in cardiovascular diseases
Oeseburg, H. (2010) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Telomeres and Aging, Cancer, and Hepatic Fibrosis
Tillmann, H. L., Plentz, R. R., Begus‐Nahrmann, Y., Lechel, A., & Rudolph, K. L. (2009) · Wiley eBooks · doi:10.1002/9780470747919.ch68
Self-citationThe Role of Genes on Chromosome Locus 4q12 in Human Central Nervous System Tumors
Blom, T. (2009) · Helda - University of Helsinki Institutional Repository
8 Direct, in situ assessment of telomere length variation in human cancers and preneoplastic lesions
Meeker, A. K., Gage, W. R., Marzo, A. D., & Maitra, A. (2002) · Handbook of immunohistochemistry and in situ hybridization of human carcinomas · doi:10.1016/s1874-5784(02)80014-9
Genetic Requirements for the Transformation of Human Cells
Seger, Y. R. (2002) · Defense Technical Information Center (DTIC) · doi:10.21236/ada410207
Genome-destabilizing and Mutagenic Effects of Break-induced Replication in Saccharomyces cerevisiae
Deem, A. K. (2011) · Purdue e-Pubs (Purdue University System) · doi:10.7912/c2/2131
Brooksbank, C. (2001) · Nature Reviews Genetics · doi:10.1038/35080500
Genetic Studies of Acute Lymphoblastic Leukemia
Kuchinskaya, E. (2007) · Figshare · Cited by 1
Telomerase: target for cancer treatment
Shay, J. W., & Wright, W. E. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139046947.038
Development of adenoviral vectors for monitoring telomerase activity in living cells
Edqvist, A. (2007) · Lund University Publications (Lund University)
Hultdin, M. (2003) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 1
Telomeres and Telomerase in Adrenocortical Carcinoma
Else, T., & Hornsby, P. J. (2009) · Springer eBooks · doi:10.1007/978-0-387-77236-3_13
“has been detected at the stage of high-grade dysplasia and carcinoma in situ but not in adenomas [ 64 , 67].”
BackgroundLe système de réparation des mésappariements contrôle la stabilité des télomères
Brunori, M., Gilson, É., & Puisieux, A. (2001) · médecine/sciences · doi:10.1051/medsci/200117111184 · Cited by 1
“D’abord, l’érosion progressive de l’ADN télomérique lors de la division des cellules crée une source d’instabilité génétique qui conduit normalement à la sénescence, mais peut aussi favoriser l’apparition d’altérations à l’origine du processus de transformation maligne [1].”
Up a gear? The significance of an elevated mutation rate in tumorigenesis
Page, K. M. (2007) · Physics of Life Reviews · doi:10.1016/j.plrev.2007.04.001
The Influence of Biological Ageing in the Pathogenesis of Colorectal Cancer
Maxwell, F. (2013) · Enlighten: Theses (The University of Glasgow) · Cited by 1
Telomeres, Telomerase, and DNA Damage Response in Cancer Therapy
Tamakawa, R., Fleisig, H. B., & Wong, J. M. Y. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4741-2_11
“Indeed, data from tumor cytogenetic studies have demonstrated that telomere length from precancerous lesions are much shorter than in normal tissues [ 12, 190, 191 ] .”
BackgroundSpontaneous Neoplasia: A Destiny of Viviparous Mammal
Mingomataj, E., & Shyri, R. M. (2013)
Mechanisms of Gastrointestinal Carcinogenesis
Scott, F. I., & Lynch, J. P. (2012) · Molecular pathology library · doi:10.1007/978-1-4614-6015-2_1
La inestabilitat cromosòmica en el càncer colorectal
Camps, J. (2005) · Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona)
Empresa Brasileira de Pesquisa Agropecuária Conselho de Administração
Cardoso, F., de Almeida, M. F., Portugal, A. D., Quast, D. G., Accarini, J. H., Fausto, S., & Ribeiral, U. C. (2001)
Importance of Fluorescent In Situ Hybridization in Rodent Tumors
Mendes-da-Silva, A., Adega, F., & Chaves, R. (2015) · Springer eBooks · doi:10.1007/978-1-4939-1516-3_3 · Cited by 2
“Several are the studies reporting the relation between telomere shortening and tumor progression [ 64 , 131 , 132 ].”
BackgroundKhurana, S., & Katiyar, S. (2011)
Bhartiya, U. S., Agrawal, A., Joseph, L. J., Raut, Y. S., Hawaldar, R. W., Nayak, U., Asopa, R. V., & Mgr, R. (2016) · Indian Journal Of Applied Research
Aging of Mammalian Intestinal Stem Cells
Sperka, T., & Rudolph, K. L. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1232-8_9
Self-citationConsequences of telomerase inhibition and telomere dysfunction in BRCA1 mutant cancer cells
Phipps, E. A. (2014) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1953
Neoplasia of the Gastrointestinal Tract
Margalit, O., & DuBois, R. N. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch31
Assessment of Missense Alterations in MLH1 and their Pathogenic Significance
Perera, N. S. (2010) · TSpace (University of Toronto)
Role of cancer stem cells in breast and prostate cancer
Wright, N. (2016) · SHURA (Sheffield Hallam University Research Archive) (Sheffield Hallam University)
Telomerase-Deficient Mouse Model
Samper, E., & Blasco, M. A. (2003) · CRC Press eBooks · doi:10.1201/9780203911709.ch22
Mechanisms of Gastrointestinal Malignancies
Lynch, J. P., & Rustgi, A. K. (2006) · Elsevier eBooks · doi:10.1016/b978-012088394-3/50020-9
Copy-Number Alterations in the Colorectal Cancer Genome
Kim, J., & Bass, A. J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8412-7_10
Metadata
- Authors
- Rudolph, K. L., Millard, M., Bosenberg, M. W., & DePinho, R. A.
- Affiliations
- Dana-Farber Cancer Institute (US)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Corresponding author
- DePinho, Ronald A.
- Venue
- Nature Genetics
- Published
- 2001-06
- Volume
- 28
- Issue
- 2
- Pages
- 155-159
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1483245334
- Cited by
- 527
- References
- 31
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 9 · 2023: 10 · 2022: 8 · 2021: 13 · 2020: 8 · 2019: 12 · 2018: 11 · 2017: 10 · 2016: 16 · 2015: 18 · 2014: 16 · 2013: 26 · 2012: 27
- FWCI
- 26.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- telomere dysfunction, telomerase activation, colorectal carcinogenesis, chromosomal instability, ApcMin/+ mice, TP53 mutation, anaphase bridges, tumor progression, tumor initiation, genome stability
- MeSH terms
- Adenocarcinoma, Adenoma, Animals, Cytoskeletal Proteins, Humans, Intestinal Neoplasms, Mice, Inbred C57BL, Mice, Mutant Strains, RNA, Colorectal Neoplasms, Tumor Suppressor Protein p53, Telomere, Apoptosis, Telomerase, Adenomatous Polyposis Coli Protein, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.